Feb. 6, 2020 Price forecast | 2 weeks: 1.01% | 1 month: -2.90% | 3 months: -6.60%

NGM stock forecast

Our latest prediction for NGM Biopharmaceuticals, Inc.'s stock price was made on the Feb. 6, 2020 when the stock price was at 15.84$.

In the short term (2weeks), NGM's stock price should outperform the market by 1.01%. During that period the price should oscillate between -8.30% and +9.74%.

In the medium term (3months), NGM's stock price should underperform the market by -6.60%. During that period the price should oscillate between -29.08% and +25.19%.

About NGM Biopharmaceuticals, Inc.

NGM Biopharmaceuticals, Inc. engages in the discovery and development of therapeutics for major diseases with an initial focus on cardio-metabolic and liver diseases. Its portfolio if composed of product candidates which focuses on non-alcoholic steatohepatitis, type 2 diabetes, obesity, oncology and age-related macular degeneration. The company was founded by Jin-Long Chen in 2008 and is headquartered in South San Francisco, CA.

At the moment the company generates 120M USD in revenues.

On its last earning announcement, the company reported a loss of -0.19$ per share.

The book value per share is 2.88$

NGM Biopharmaceuticals, Inc. website

Three months stock forecastFeb. 6, 2020


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
120M - -19M -15.90% -13M -0.19 - - 66M 2.88 -20M -3M -22M